volume 79, issue 2, P671-681 2021
DOI: 10.3233/jad-201167
View full text
Melissa E. Petersen, Michael S. Rafii, Fan Zhang, James Hall, David Julovich, Beau M. Ances, Nicole Schupf, Sharon J. Krinsky-McHale, Mark Mapstone, Wayne Silverman, Ira Lott, William Klunk, Elizabeth Head, Brad Christian et al.

Abstract: Background: The need for diagnostic biomarkers of cognitive decline is particularly important among aging adults with Down syndrome (DS). Growing empirical support has identified the utility of plasma derived biomarkers among neurotypical adults with mild cognitive impairment (MCI) and Alzheimer’s disease (AD); however, the application of such biomarkers has been limited among the DS population. Objective: This study aimed to investigate the cross-sectional diagnostic performance of plasma neurofilament light …

expand abstract